Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect ; 73(2): 115-22, 2016 08.
Article in English | MEDLINE | ID: mdl-27246801

ABSTRACT

OBJECTIVES: We aim to study the disease burden, risk factors and severity of Clostridium difficile infection (CDI) in Hong Kong. METHODS: We conducted a prospective, case-control study in three acute-care hospitals in Hong Kong. Adult inpatients who developed CDI diarrhoea confirmed by PCR (n = 139) were compared with the non-CDI controls (n = 114). Ribotyping of isolates and antimicrobial susceptibility testing were performed. RESULTS: The estimated crude annual incidence of CDI was 23-33/100,000 population, and 133-207/100,000 population among those aged ≥65 years. The mean age of CDI patients was 71.5. Nursing home care, recent hospitalization, antibiotics exposure (adjusted OR 3.0, 95% CI 1.3-7.1) and proton-pump inhibitors use (adjusted OR 2.2, 95% CI 1.2-3.9) were risk factors. Severe CDI occurred in 41.7%. Overall mortality was 16.5% (among severe CDI, 26.5%). The commonest ribotypes were 002 (22.8%), 014 (14.1%), 012 and 046; ribotype 027 was absent. Ribotype 002 was associated with fluoroquinolone resistance and higher mortality (47.6% vs. 12.7%; adjusted HR 2.8, 95% CI 1.1-7.0). CONCLUSIONS: Our findings show high morbidity and mortality of CDI in the older adults, and identify ribotype 002 as a possible virulent strain causing serious infections in this cohort.


Subject(s)
Clostridioides difficile/pathogenicity , Clostridium Infections/epidemiology , Clostridium Infections/microbiology , Cross Infection/epidemiology , Ribotyping , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Case-Control Studies , Clostridioides difficile/classification , Clostridioides difficile/genetics , Clostridioides difficile/isolation & purification , Clostridium Infections/immunology , Clostridium Infections/mortality , Colitis/drug therapy , Colitis/microbiology , Cost of Illness , Cross Infection/microbiology , Diarrhea/epidemiology , Diarrhea/microbiology , Female , Fluoroquinolones/therapeutic use , Hong Kong/epidemiology , Humans , Incidence , Male , Middle Aged , Polymerase Chain Reaction , Prospective Studies , Risk Factors , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...